Evaluation of a HEPA Filter Pilot Project: Formative Data to Support a Future Indoor Air Quality Bronchiolitis Clinical Trial

HEPA 过滤器试点项目的评估:支持未来室内空气质量毛细支气管炎临床试验的形成性数据

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Alaska Native and American Indian (ANAI) children experience a high burden of acute and chronic respiratory disease. Wood stove use, poor ventilation, and indoor tobacco smoke exposure have all been shown to cause poor indoor air quality (IAQ), which is associated with increased severity and frequency of respiratory infections in children. Portable HEPA purifiers have been shown to be effective in reducing particulate matter from tobacco and nontobacco smoke; however, despite demonstrated links between early-life severe respiratory infections, pediatric asthma, and adult pulmonary outcomes, no randomized trials to improve IAQ and associated health outcomes in children with bronchiolitis have been conducted. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is developing a protocol for a clinical trial to address this gap. The proposal, “Reduction of indoor air pollution with high efficiency particulate air (HEPA) filtration to decrease respiratory symptom burden after hospitalization for bronchiolitis (IAQ bronchiolitis) is a placebo-controlled, multicenter clinical trial that aims to evaluate the efficacy of active HEPA filtration units, as compared with inactive HEPA filtration units, for reducing respiratory symptoms and increasing symptom-free days in children <12 months of age hospitalized with bronchiolitis. In 2019 the YK Health Corporation (YKHC) conducted a pilot project to provide education, HEPA filtration units and Healthy Homes Toolkits to households of children with chronic lung conditions such as bronchiectasis in the rural Yukon Kuskokwim Delta region of Alaska. In this diversity supplement, we will leverage and expand on a longstanding partnership between the Alaska ISPCTN investigators and YKHC to conduct an analysis of data from this 2019 pilot. We will assess the associations between household characteristics and HEPA filtration use, including duration of use. We will also compare household characteristics of homes with and without tobacco smokers. The proposed diversity supplement project will use existing data to support and expand the IAQ bronchiolitis trial and the ECHO focus area of upper and lower airway disease. Alaska Native/American Indian (AN/AI) people are under-represented in the medical profession and only 0.5% of We plan to mentor Madilyn Short, an Alaska Native (Yup’ik/Inupiat), first-year medical student from the rural Yukon Kuskokwim (YK) Delta region of Alaska, in a collaborative study between the Alaska ISPCTN and the Yukon Kuskokwim Health Corporation (YKHC). Madilyn is currently working as a research intern/assistant with Dr. Singleton and the Alaska Native Tribal Health Consortium’s Research Services and plans to complete her medical training and eventually practice medicine in Alaska with Alaska Native people.
项目总结/摘要 阿拉斯加原住民和美洲印第安人(ANAI)的儿童经历了严重的急性和 慢性呼吸道疾病使用木柴炉,通风不良,室内有烟草烟雾 暴露都被证明会导致室内空气质量差(IAQ),这与 儿童呼吸道感染的严重程度和频率增加。便携式HEPA净化器 已被证明可有效减少烟草和非烟草中的颗粒物 吸烟;然而,尽管已证明早期严重呼吸道感染, 儿童哮喘和成人肺部结局,没有改善IAQ的随机试验, 已对毛细支气管炎儿童的相关健康结果进行了研究。这个想法 美国儿科临床试验网络(ISPCTN)正在制定一项临床试验方案, 弥补这一差距。该提案,“减少室内空气污染的高效微粒 空气(HEPA)过滤,以减少住院后的呼吸道症状负担 细支气管炎(IAQ细支气管炎)是一项安慰剂对照的多中心临床试验,旨在 评估活性HEPA过滤装置的效率,与非活性HEPA过滤装置相比 单位,用于减少12岁以下儿童的呼吸道症状和增加无哮喘天数 月龄因细支气管炎住院。 2019年,YK健康公司(YKHC)开展了一个试点项目,提供教育, 为慢性肺病儿童家庭提供HEPA过滤装置和健康家庭工具包 在阿拉斯加的农村育空地区Kuskokwim三角洲地区,在这 多样性补充,我们将利用和扩大之间的长期伙伴关系, 阿拉斯加ISPCTN调查人员和YKHC将对2019年试点的数据进行分析。我们 将评估家庭特征与HEPA过滤使用之间的关联, 包括使用期限。此外,我们亦会比较两个家庭的住户特征, 没有吸烟者。拟议的多样性补充项目将利用现有数据, 支持和扩大IAQ细支气管炎试验和ECHO重点领域的上,下 呼吸道疾病 阿拉斯加原住民/美洲印第安人(AN/AI)在医学界的代表性不足 只有0.5%的人计划指导Madilyn Short,阿拉斯加原住民(Yup'ik/Inupiat),第一年 来自阿拉斯加州农村育空地区Kuskokwim(YK)三角洲地区的医学生,在一个合作项目中 阿拉斯加ISPCTN和育空地区Kuskokwim卫生公司(YKHC)之间的研究。 Madilyn目前在Singleton博士和阿拉斯加大学担任研究实习生/助理。 土著部落健康联盟的研究服务,并计划完成她的医疗 在阿拉斯加与阿拉斯加原住民一起培训并最终行医。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew J Hirschfeld其他文献

Matthew J Hirschfeld的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew J Hirschfeld', 18)}}的其他基金

Building research capacity within tribal organizations for research to improve the health of Alaska Native children
建设部落组织的研究能力,以改善阿拉斯加原住民儿童的健康
  • 批准号:
    10063404
  • 财政年份:
    2016
  • 资助金额:
    $ 0.83万
  • 项目类别:
Building research capacity within tribal organizations for research to improve the health of Alaska Native children
建设部落组织的研究能力,以改善阿拉斯加原住民儿童的健康
  • 批准号:
    10470175
  • 财政年份:
    2016
  • 资助金额:
    $ 0.83万
  • 项目类别:
Building research capacity within tribal organizations for research to improve the health of Alaska Native children
建设部落组织的研究能力,以改善阿拉斯加原住民儿童的健康
  • 批准号:
    10683208
  • 财政年份:
    2016
  • 资助金额:
    $ 0.83万
  • 项目类别:
Building research capacity within tribal organizations for research to improve the health of Alaska Native children
建设部落组织的研究能力,以改善阿拉斯加原住民儿童的健康
  • 批准号:
    10246528
  • 财政年份:
    2016
  • 资助金额:
    $ 0.83万
  • 项目类别:
Building research capacity within tribal organizations for research to improve the health of Alaska Native children
建设部落组织的研究能力,以改善阿拉斯加原住民儿童的健康
  • 批准号:
    10675906
  • 财政年份:
    2016
  • 资助金额:
    $ 0.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了